F X Nottingham and F X Taunton Two Novel Mutations in Factor X Resulting in Loss of Functional Activity and an Interpretation Using Molecular Modelling

S. Deam; N. Srinivasan; J. Westby; E.H. Horn; G. Dolan

doi:10.1055/s-0037-1615695

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2001; 85(02): 265-269
DOI: 10.1055/s-0037-1615695

Review Article

Schattauer GmbH

F X Nottingham and F X Taunton Two Novel Mutations in Factor X Resulting in Loss of Functional Activity and an Interpretation Using Molecular Modelling

S. Deam

¹Departments of Haematology and Clinical Chemistry, Queen’s Medical Centre, Nottingham, UK

,

N. Srinivasan

²Molecular Biophysics Unit, Indian Institute of Science, Bangalore, India

,

J. Westby

¹Departments of Haematology and Clinical Chemistry, Queen’s Medical Centre, Nottingham, UK

,

E.H. Horn

³Department of Haematology, Royal Infirmary, Edinburgh, UK

,

G. Dolan

¹Departments of Haematology and Clinical Chemistry, Queen’s Medical Centre, Nottingham, UK

› Institutsangaben

Abstract

Summary

We report two novel mutations in the Factor X gene which result in a bleeding tendency in two unrelated Caucasian families. Although the mutations occur at adjacent codons in exon 8 and result in reduced functional activity with normal antigen levels, the patterns of inheritance appear to be quite distinct. Factor X Nottingham (alanine 404 threonine) appears to be associated with an autosomal recessive pattern of inheritance. In contrast, Factor X Taunton (arginine 405 glycine) results in a mode of inheritance consistent with an autosomal dominant pattern, all five of the heterozygotes in this family being clinically affected. Molecular modelling studies suggest that, in the case of Factor X Nottingham, a drastic conformational change causes major unfolding of the protein. For Factor X Taunton, less extreme conformational changes occur causing loss of functional activity such that substrate binding sites might be maintained. It is proposed that competition with wild type for substrate binding could occur leading to a dominant negative effect.

Key words

Factor X mutations molecular modelling

Volltext

Referenzen

References
1 Perry DJ. Factor X and its deficiency states. Haemophilia 1997; 3: 159-72.
2 Padmanabhan K, Padmanabhan KP, Tulinsky A, Park CH, Bode W, Huber R, Blankenship DT, Cardin AD, Kisiel W. Structure of human Des(1-45) Factor Xa at 2.2 Å resolution. J Med Biol 1993; 232: 947-66.
3 Royle NJ, Fung MR, MacGillivray RTA, Hamerton JL. The gene for clotting factor 10 is mapped to 13q32 qter. Cytogenet Cell Genet 1986; 41: 185-8.
4 Leytus SP, Foster DC, Kurachi K, Davie EW. Gene for human Factor X: A blood coagulation factor whose gene organization is essentially identical with that of Factor IX and Protein C. Biochemistry 1986; 25: 5098-102.
5 Fung MR. Molecular genetics of blood coagulation factor X. Thesis, University of British Columbia Vancouver, Canada: 1988
6 Jagadeaswaran P, Reddy SV, Rao KJ, Hamsabhushanam K, Lyman G. Cloning and characterisation of the 5′ end (exon 1) of the gene encoding human factor X, a blood coagulation factor. Gene 1989; 84: 517-9.
7 Cooper DN, Millar DS, Wacey A, Pemberton S, Tuddenham EGD. Inherited Factor X deficiency: Molecular genetics and pathophysiology. Thromb Haemost 1997; 78 (Suppl. 01) 161-72.
8 Miyata T, Kojima T, Suzuki K, Umeyama H, Yamazaki T, Kamiya T, Toyoda H, Kato H. Factor X Nagoya 1 and Nagoya 2: a CRM-Factor X Deficiency Characterized by substitution of Arg306 by Cys and of Gly366 by Ser, respectively. Thromb Haemost 1998; 79: 486-90.
9 Miyata T, Fischer F, Umeyama H, Appert A, Jambou D, Kato H. Factors X Nice I and II: Two novel missense mutations (Met –40Val and Pro304Ser) in a patient with coagulation Factor X deficiency. Thromb Haemost 1998; 80: 709-10.
10 Nobauer IM, Holler W, Krinninger B, Turecek PL, Richter G, Scharrer I, Forberg E, Watzke HH. Factor X Frankfurt I: molecular and functional characterization of a hereditary factor X deficiency (Gla25 to Lys). Blood Coagulation and Fibrinolysis 1998; 9: 143-52.
11 James HL, Girolami A, Fair DS. Molecular defect in coagulation Factor XFruili results from a substitution of serine for proline at position 343. Blood 1991; 772: 317-23.
12 Bernstein FC, Koetzle TF, Williams GJB, Beyer Jr EF, Brice MD, Rodgers JR, Kennard O, Shimanouchi T, Tasumi M. The protein data bank: A computer archival file for macromolecular structures. J Mol Biol 1977; 112: 535-42.
13 Sutcliffe MJ, Hayes FRF, Blundell TL. Knowledge based modeling of homologous proteins: rules for the conformations of substituted side-chains. Prot Engng 1987; 1: 385-92.
14 Weiner SJ, Kollman PA, Case DA, Singh UC, Ghio C, Alagona G, Profeta S, Weiner P. A new force-field for molecular mechanical simulation of nucleic acids and proteins. J Am Chem Soc 1984; 106: 765-84.
15 Evans SV. SETOR-Hardware-lighted 3-dimensional solid model representations of macromolecules. J Mol Graph 1993; 11: 134-8.
16 Altschul SF, Madden TL, Schaffer AA, Zhang JH, Zhang Z, Miller W, Lipman DJ. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucl Acid Res 1997; 25: 3389-402.
17 Johnson MS, Overington JP, Blundell TL. Alignment and searching for common protein folds using a data-bank of structural templates. J Mol Biol 1993; 231: 735-52.
18 Sali A, Blundell TL. Definition of general topological equivalence in protein structures – a procedure involving comparison of properties and relationships through simulated annealing and dynamic-programming. Mol Biol 1990; 212: 403-28.
19 Zhu ZY, Sali A, Blundell TL. A variable gap penalty-function and feature weights for protein 3-D structure comparisons. Prot Engng 1992; 5: 43-51.
20 Messier TL, Pittman DD, Long GL, Kaufman RJ, Church WR. Cloning and expression in COS-1 cells of a full-length cDNA encoding human coagulation Factor X. Gene 1991; 99: 291-4.
21 Wallmark A, Rose V, Coty H, High K. A NlaIV polymorphism within the Factor X gene. Nucleic Acids Research 1991; 19 (Suppl. 14) 4022.
22 Messier TL, Wong CY, Bovill EG, Long GL, Church WR. Factor X Stockton : a mild bleeding diathesis associated with an active site mutation in Factor X. Blood Coag Fibrinolysis 1996; 7: 5-14.
23 Chattopadhay A, James HL, Fair DS. Molecular recognition sites on factor Xa which participate in the prothrombinase complex. J Biol Chem 1992; 267: 12323-9.